Athira Pharma, Inc. (ATHA)

Athira Pharma Statistics

Total Valuation

Athira Pharma has a market cap or net worth of $17.88 million. The enterprise value is -$17.67 million.

Market Cap	17.88M
Enterprise Value	-17.67M

Important Dates

The next estimated earnings date is Monday, August 4, 2025, after market close.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Athira Pharma has 39.04 million shares outstanding. The number of shares has increased by 1.42% in one year.

Current Share Class	39.04M
Shares Outstanding	39.04M
Shares Change (YoY)	+1.42%
Shares Change (QoQ)	+0.88%
Owned by Insiders (%)	14.09%
Owned by Institutions (%)	23.03%
Float	24.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.26, with a Debt / Equity ratio of 0.03.

Current Ratio	7.26
Quick Ratio	6.68
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -110.70% and return on invested capital (ROIC) is -67.00%.

Return on Equity (ROE)	-110.70%
Return on Assets (ROA)	-55.53%
Return on Invested Capital (ROIC)	-67.00%
Return on Capital Employed (ROCE)	-206.79%
Revenue Per Employee	n/a
Profits Per Employee	-$3.07M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.12% in the last 52 weeks. The beta is 2.99, so Athira Pharma's price volatility has been higher than the market average.

Beta (5Y)	2.99
52-Week Price Change	-86.12%
50-Day Moving Average	0.34
200-Day Moving Average	0.43
Relative Strength Index (RSI)	65.56
Average Volume (20 Days)	282,407

Short Selling Information

The latest short interest is 1.03 million, so 2.65% of the outstanding shares have been sold short.

Short Interest	1.03M
Short Previous Month	1.32M
Short % of Shares Out	2.65%
Short % of Float	4.15%
Short Ratio (days to cover)	4.25

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-78.62M
Pretax Income	-113.45M
Net Income	-79.75M
EBITDA	-77.65M
EBIT	-78.62M
Earnings Per Share (EPS)	-$2.06

Balance Sheet

The company has $36.67 million in cash and $1.12 million in debt, giving a net cash position of $35.55 million or $0.91 per share.

Cash & Cash Equivalents	36.67M
Total Debt	1.12M
Net Cash	35.55M
Net Cash Per Share	$0.91
Equity (Book Value)	37.33M
Book Value Per Share	0.96
Working Capital	34.36M

Cash Flow

In the last 12 months, operating cash flow was -$86.03 million and capital expenditures -$28,000, giving a free cash flow of -$86.06 million.

Operating Cash Flow	-86.03M
Capital Expenditures	-28,000
Free Cash Flow	-86.06M
FCF Per Share	-$2.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Athira Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.42%
Shareholder Yield	-1.42%
Earnings Yield	-445.97%
FCF Yield	-481.28%

Analyst Forecast

The average price target for Athira Pharma is $11.25, which is 2,356.33% higher than the current price. The consensus rating is "Buy".

Price Target	$11.25
Price Target Difference	2,356.33%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1